Supernus Pharmaceuticals, Inc. (SUPN)
41.64
-0.05
(-0.12%)
USD |
NASDAQ |
Sep 11, 16:00
41.65
+0.01
(+0.02%)
After-Hours: 20:00
Supernus Pharmaceuticals Price : 41.64 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 41.81 | 42.44 | 41.62 | 41.64 | 707160.0 |
| Sep 10, 2026 | 41.84 | 42.55 | 41.11 | 41.69 | 726750.0 |
| Sep 09, 2026 | 42.17 | 42.59 | 41.50 | 42.07 | 580434.0 |
| Sep 08, 2026 | 43.56 | 43.56 | 42.32 | 42.43 | 429134.0 |
| Sep 04, 2026 | 43.66 | 44.11 | 43.43 | 43.53 | 444197.0 |
| Sep 03, 2026 | 44.56 | 44.56 | 43.16 | 43.97 | 390321.0 |
| Sep 02, 2026 | 44.42 | 45.04 | 43.67 | 44.03 | 445942.0 |
| Sep 01, 2026 | 44.35 | 44.75 | 43.53 | 43.74 | 757781.0 |
| Aug 31, 2026 | 43.82 | 44.37 | 42.84 | 44.21 | 535722.0 |
| Aug 28, 2026 | 43.95 | 44.34 | 43.12 | 43.73 | 487926.0 |
| Aug 27, 2026 | 44.87 | 45.04 | 43.89 | 44.19 | 464947.0 |
| Aug 26, 2026 | 45.11 | 45.43 | 44.50 | 44.88 | 499685.0 |
| Aug 25, 2026 | 45.37 | 45.86 | 44.22 | 45.36 | 496056.0 |
| Aug 24, 2026 | 45.60 | 45.86 | 44.82 | 45.11 | 495506.0 |
| Aug 21, 2026 | 47.71 | 47.82 | 45.79 | 45.85 | 748894.0 |
| Aug 20, 2026 | 47.86 | 48.26 | 46.93 | 47.45 | 646851.0 |
| Aug 19, 2026 | 49.50 | 49.82 | 48.51 | 48.54 | 797224.0 |
| Aug 18, 2026 | 48.80 | 49.57 | 48.54 | 49.03 | 592240.0 |
| Aug 17, 2026 | 47.66 | 48.66 | 47.66 | 48.27 | 536730.0 |
| Aug 14, 2026 | 46.70 | 48.39 | 46.57 | 48.27 | 331732.0 |
| Aug 13, 2026 | 47.74 | 48.18 | 46.87 | 47.15 | 667872.0 |
| Aug 12, 2026 | 47.15 | 47.92 | 46.26 | 47.87 | 667316.0 |
| Aug 11, 2026 | 47.01 | 48.60 | 46.77 | 46.88 | 669685.0 |
| Aug 10, 2026 | 47.11 | 47.72 | 46.47 | 47.07 | 762175.0 |
| Aug 07, 2026 | 47.00 | 47.88 | 46.43 | 47.64 | 702627.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Indivior Pharmaceuticals, Inc. | 34.49 |
| Pfizer Inc. | 27.72 |
| Amphastar Pharmaceuticals, Inc. | 23.78 |
| Collegium Pharmaceutical, Inc. | 22.75 |
| Bristol Myers Squibb Co. | 63.64 |
Price Related Metrics
| PS Ratio | 2.878 |
| Price to Book Value | 2.349 |
| Price to Free Cash Flow | 127.23 |
| Earnings Yield | -4.60% |
| Market Cap | 2.422B |